A Phase I/II trial of focal carbon-ion radiotherapy using 4 fractions for the patients with local recurrence prostate cancer after radiotherapy
Phase 1
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000028630
- Lead Sponsor
- QST Hospital, National Institutes for Quantum Science and Technology Treatment division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Other salvage therapy has been performed except for the case with positive local recurrence by biopsy after discontinuance of hormonal therapy 2) Presence of biopsy proven separate lesions except for visible lesion in MRI. 3) Having at least one factor of GS>9, T3b and PSA > 40 ng/ml before initial radical radiotherapy. 4) occuring Grade 3 or more severe adverse effect after initial radical radiotherapy. 5) Ineligible dose constraint of risk organs 6) Considered to be castration resistant prostate cancer 7) Presence of active double cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method